News

Filter

Current filters:

None

7913 to 7922 of 96157 results

IFPMA tightens Code of Practice for health interactions

02-03-2012

The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) Code of Practice…

BiotechnologyGlobalMarkets & MarketingPharmaceutical

Galapagos leaps on $1.35 billion RA drug deal with Abbott Labs

01-03-2012

Belgian drug developer Galapagos (Euronext: GLPG) saw its shares rocket 27% to a record high 13.89 euros…

Abbott LaboratoriesAnti-Arthritics/RheumaticsBiotechnologyGalapagosLicensingPharmaceutical

Biogen Idec files oral MS candidate in USA

01-03-2012

US biotech firm Biogen Idec (Nadaq: BIIB) has submitted its orally-active drug for relapsing-remitting…

Biogen IdecBiotechnologyNeurologicalRegulation

Genzyme to start shipping Fabrazyme from newly-approved plant

01-03-2012

French drug major Sanofi's (Euronext: SAN) US subsidiary Genzyme says that it has begun shipping its…

BiotechnologyFabrazymeGenzymeMarkets & MarketingPharmaceuticalRare diseasesSanofi

German pharma hails progress against cancer and rare diseases

01-03-2012

Never has the pharmaceutical industry made as much progress against cancer as in the past few years,…

EuropeOncologyPharmaceuticalResearch

Unmet needs in nasopharyngeal cancer therapeutics continue to frustrate clinicians

01-03-2012

Clinicians treating patients with nasopharyngeal cancer may have to wait for the scientific breakthrough…

Markets & MarketingOncologyPharmaceuticalResearch

EMA increases public information on conflicts of interest of experts and management

01-03-2012

The European Medicines Agency this week updated its list of European experts to display each expert's…

EuropeManagementPharmaceuticalRegulation

Hi-Tech and Mylan update on generics

01-03-2012

US generic drugmaker Hi-Tech Pharmacal (Nasdaq: HITK) says that the US Food and Drug Administration has…

GenericsMarkets & MarketingNeurologicalNorth AmericaRegulation

7913 to 7922 of 96157 results

Back to top